Filing Flows › Maravai Lifesciences Holdings (MRVI) › Q3 2026
Maravai Lifesciences Holdings (MRVI) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Maravai Lifesciences Holdings (MRVI) reported revenue of $45.9M for the third quarter 2026 (Q3 2026), +10% from a year earlier and -11% from the quarter before. Operating margin was -45.0%, net loss $24.0M (52.3% of revenue).
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45.9M | -11% | +10% |
| Operating profit | −$20.6M | — | — |
| Net earnings | −$24.0M | — | — |
| Operating cash flow | $5.0M | +26% | — |
| Free cash flow | $4.5M | +24% | — |
What changed
Revenue was $45.9M in Q3 2026, up 10% year over year and down 11% from the previous quarter. TriLink was the largest line at 62% of revenue. TriLink added $3.0M year over year (up 12%), 71% of the total change.
Gross margin was 35.3%, up 21.7 points from Q3 2025. Operating costs exceeded revenue by $20.6M, an operating margin of -45.0%. Operating expenses fell 21% while revenue rose 10%. The quarter ended with a net loss of $24.0M, wider than the previous quarter's $21.6M loss. Minority interests bore $10.2M of it: to shareholders the quarter was a loss of $13.8M.
Operating cash flow was $5.0M. Non-cash charges added back $12.2M of depreciation and amortization and $10.1M of share-based compensation. Working capital and other items added $6.7M. Capital expenditures of $523K left free cash flow of $4.5M.
Questions
What was Maravai Lifesciences Holdings' revenue in the third quarter 2026?
Maravai Lifesciences Holdings (MRVI) reported revenue of $45.9M for the third quarter 2026 (Q3 2026), +10% from a year earlier and -11% from the quarter before.
Was Maravai Lifesciences Holdings profitable in the third quarter 2026?
Operating loss was $20.6M (-45.0% of revenue) and net loss $24.0M.